Dres Schlegel Plus Schmidt Med Kommunikation
Dres Schlegel Plus Schmidt Med Kommunikation, commonly referred to as Schlegel & Schmidt, is a leading player in the medical communication industry, headquartered in Germany. Founded in [year not specified], the company has established a strong presence across Europe, particularly in Germany and surrounding regions, focusing on delivering high-quality medical writing, strategic communication, and consultancy services. With a commitment to excellence, Schlegel & Schmidt offers a unique blend of scientific expertise and creative communication strategies, catering to pharmaceutical and healthcare clients. Their core services include medical writing, regulatory affairs support, and educational content development, all designed to enhance client engagement and compliance. Recognised for their innovative approach, the company has achieved notable milestones, solidifying its position as a trusted partner in the medical communications landscape.
DitchCarbon Score
How does Dres Schlegel Plus Schmidt Med Kommunikation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dres Schlegel Plus Schmidt Med Kommunikation's score of 3 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dres Schlegel Plus Schmidt Med Kommunikation's reported carbon emissions
Dres Schlegel + Schmidt Med Kommunikation, headquartered in Germany, has set ambitious climate commitments despite not having specific carbon emissions data available. The company has committed to reducing its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by the year 2030, using 2023 as the baseline year. This target has been validated through the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. In addition to its direct emissions reduction goals, the company also aims to measure and address its Scope 3 emissions, which encompass indirect emissions from its value chain. These commitments reflect a proactive approach to climate action within the healthcare sector, demonstrating a dedication to sustainability and environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dres Schlegel Plus Schmidt Med Kommunikation is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
